Hält derzeit Positionen bei Baxalta Inc, Biomarin Pharmaceutical Inc, Carmax Inc and Aptinyx Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Chief Operating Officer, Executive Vice President | Baxalta Inc | None - |
Independent Director | Biomarin Pharmaceutical Inc | 28. September 2017 - |
Independent Director | Carmax Inc | 1. April 2018 - |
Independent Director | Aptinyx Inc | 1. Mai 2018 - |
Chief Financial Officer, Corporate Vice President | Baxter International Inc | 23. März 2011 - 1. Januar 2015 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2021-11-15 | 2021-11-12 |
Aptinyx Inc
(APTX)
|
K Kauf |
74.600
+51.6%
2,40179.040 USD |
74.600 +51.6% | 2,40 | 179.040 USD | |
2021-11-15 | 2021-11-11 |
Aptinyx Inc
(APTX)
|
K Kauf |
5.400
+3.9%
2,4012.960 USD |
5.400 +3.9% | 2,40 | 12.960 USD | |
2020-01-14 | 2020-01-10 |
Aptinyx Inc
(APTX)
|
K Kauf |
50.000
+56.1%
3,00150.000 USD |
50.000 +56.1% | 3,00 | 150.000 USD | |
2019-01-28 | 2019-01-25 |
Aptinyx Inc
(APTX)
|
K Kauf |
11.655
+31.1%
5,5464.569 USD |
11.655 +31.1% | 5,54 | 64.569 USD | |
2019-01-28 | 2019-01-24 |
Aptinyx Inc
(APTX)
|
K Kauf |
13.345
+55.4%
5,5273.664 USD |
13.345 +55.4% | 5,52 | 73.664 USD |